Impact of managed care on cancer trial enrollment

Journal of Clinical Oncology

Volumn 23, Issue 16, 2005, Pages 3811-3818

  Gross, Cary P ^a   Krumholz, H M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER REGISTRY; CLINICAL RESEARCH; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRIORITY JOURNAL; PROSTATE CANCER; BREAST TUMOR; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE DELIVERY; HEALTH INSURANCE; LUNG TUMOR; PROSTATE TUMOR; REGISTER; STATISTICS; UTILIZATION REVIEW;

BREAST NEOPLASMS; CLINICAL TRIALS; COLORECTAL NEOPLASMS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LUNG NEOPLASMS; MALE; MANAGED CARE PROGRAMS; PROSTATIC NEOPLASMS; REGISTRIES;

EID: 20544443732     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.00.430     Document Type: Article

References (40)

1. Office of the Director: The Nation's Investment in Cancer Res: A Budget Proposal for Fiscal Year 2001. Bethesda, MD, National Cancer Institute, 1999
2. Sung NS, Crowley WF Jr, Genel M, et al: Central challenges facing the national clinical research enterprise. JAMA 289:1278-1287, 2003
3. Shavers-Hornaday V, Lynch C, Burmeister L, et al: Why are African-Americans underrepresented in medical research studies? Impediments to participation. Ethn Health 2:31-45, 1997
4. Foley J, Moertel C: Improving accrual into cancer clinical trials. J Cancer Educ 6:165-173, 1991
5. Fleming I: Clinical trials for cancer patients: The community practicing physician's perspective. Cancer 65:2388-2390, 1990
6. Fallowfield L, Ratcliffe D, Souhami R: Clinicians' attitudes to clinical trials of cancer therapy. Eur J Cancer 33:2221-2229, 1997
7. Swanson D, Ward A: Recruiting minorities into clinical trials: Toward a participant-friendly system. J Natl Cancer Inst 87:1747-1759, 1995
8. Gifford AL, Cunningham WE, Heslin KC, et al: Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med 346:1373-1382, 2002
9. Comis R, Aldige C, Stovall E, et al: A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials. http://www.cancertrialshelp.org/ cnccg_info/news.html, 2000
10. Hutchins L, Unger J, Crowley J, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061-2067, 1999
11. Goodman C: Investigational exclusion, clinical trials, and cancer. NCCN Proceedings 12:37-49, 1998
12. Vogelzang N, Richards J: Third party reimbursement issues during a phase I trial of interleukin-2. J Nat Cane Inst 81:544-545, 1989
13. NIH Clinical Trials: Various Factors Affect Patient Participation. Washington, DC, US General Accounting Office, 1999
14. Emanuel EJ, Schnipper LE, Kamin DY, et al: The costs of conducting clinical research. J Clin Oncol 21:4145-4150, 2003
15. Wade J, Weinberg P, Bennett C: The effects of managed care on community clinical research. Primary Care Cancer 19:18-25, 1999
16. Fleming R: Barriers to clinical trials, part I: Reimbursement problems. Cancer 74:2662-2665, 1994
17. Chaturvedi S: Clinical trials and financial reimbursement. Stroke 29:1256, 1998
18. Ta KT, Persing JA, Chauncey H Jr, et al: Effects of managed care on teaching, research, and clinical practice in academic plastic surgery. Ann Plast Surg 48:348-354, 2002
19. Levitt S: Impact of managed care on scholarly activity and patient care: Case study of 12 academic radiology and radiation oncology departments. Radiology 216:618-623, 2000
20. Campbell EG, Weissman JS, Causino N, et al: Market competition and patient-oriented research: The results of a national survey of medical school faculty. Acad Med 76:1119-1126, 2001
21. Campbell E, Weissman J, Blumenthal D: Relationship between market competition and activities and attitudes of medical school faculty. JAMA 278:222-226, 1997
22. Moy E, Mazzaschi A, Levin R, et al: Relationship between National Institutes of Health research awards to US medical schools and managed care market penetration. JAMA 278: 217-221, 1997
23. Wholey D, Christianson J, Engber J, et al: HMO market structure and performance. Health Aff (Millwood) 16:75-84, 1997
24. Gaskin DJ, Hadley J: The impact of HMO penetration on the rateo of hospital cost inflation. Inquiry 34:205-216, 1997
25. Publications I: County Surveyor Database 3.0. St Paul, MN, 2003
26. Quality Resource Systems I: http://www.arfsys.com/
27. Warren J, Klabunde C, Schrag D, et al: Overview of SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40: IV-3-IV-18, 2002 (suppl)
28. Stata SS: Release: 8.0 Reference Manual. College Station, TX, Stata Press, 2004
29. Society AC: Cancer facts and figures. 2000
30. Sateren WB, Trimble EL, Abrams J, et al: How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20:2109-2117, 2002
31. Burnett D: Evolving market will change clinical research. Health Aff (Millwood) 15:89-92, 1996
32. Mortonson L, Leader S, Mallick R: The impact of managed care on oncology practice. Oncology Issues 12:22-27, 1997
33. Mechanic RE, Dobson A: The impact of managed care on clinical research: A preliminary investigation. Health Aff (Millwood) 15:72-89, 1996
34. anonymous: The Nation's Investment in research: A plan and budget proposal for fiscal year 2004. Bethesda, MD, National Cancer Institute, 2003
35. Gorkin L, Schron EB, Handshaw K, et al: Clinical trial enrollers vs. nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project. Control Clin Trials 17:46-59, 1996
36. Pace C, Miller FG, Danis M: Enrolling the uninsured in clinical trials: An ethical perspective. Crit Care Med 31:5121-5125, 2003
37. Lewis JH, Kilgore ML, Goldman DP, et al: Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383-1389, 2003
38. Ferrante JM, Gonzalez EC, Roetzheim RG, et al: Clinical and demographic predictors of late-stage cervical cancer. Arch Fam Med 9:439-445, 2000
39. Roetzheim RG, Pal N, Tennant C, et al: Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 91:1409-1415, 1999
40. Wright J, Levine M: Researching the cost of research. J Clin Oncol 21:4081-4082, 2003